Grant R. Budas

4.3k total citations · 1 hit paper
49 papers, 3.0k citations indexed

About

Grant R. Budas is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Grant R. Budas has authored 49 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 20 papers in Pathology and Forensic Medicine and 17 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Grant R. Budas's work include Cardiac Ischemia and Reperfusion (19 papers), Cardiac electrophysiology and arrhythmias (15 papers) and Liver Disease Diagnosis and Treatment (8 papers). Grant R. Budas is often cited by papers focused on Cardiac Ischemia and Reperfusion (19 papers), Cardiac electrophysiology and arrhythmias (15 papers) and Liver Disease Diagnosis and Treatment (8 papers). Grant R. Budas collaborates with scholars based in United States, United Kingdom and Germany. Grant R. Budas's co-authors include Daria Mochly‐Rosen, Aleksandar Jovanović, Eric N. Churchill, Marie‐Hélène Disatnik, Russell M. Crawford, Che-Hong Chen, Thomas D. Hurley, Harri Ranki, Mair E. A. Churchill and Qingyou Du and has published in prestigious journals such as Science, Journal of Biological Chemistry and Circulation.

In The Last Decade

Grant R. Budas

45 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Activation of Aldehyde Dehydrogenase-2 Reduces Ischemic Damage to the Heart

2008 632 citations Grant R. Budas, Eric N. Churchill et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Grant R. Budas United States	29	1.5k	1.2k	776	478	345	49	3.0k
Roberta Menabò Italy	26	2.0k 1.3×	908 0.8×	581 0.7×	589 1.2×	229 0.7×	44	3.3k
Csaba Csonka Hungary	29	800 0.5×	925 0.8×	610 0.8×	568 1.2×	175 0.5×	78	2.5k
Xin L. United States	27	1.3k 0.9×	812 0.7×	1.1k 1.4×	1.0k 2.1×	807 2.3×	44	3.4k
Masaya Tanno Japan	36	2.2k 1.4×	1.2k 1.0×	949 1.2×	875 1.8×	706 2.0×	122	4.6k
Henry M. Honda United States	23	1.0k 0.7×	723 0.6×	399 0.5×	288 0.6×	214 0.6×	42	2.2k
T Ravíngerová Slovakia	30	1.1k 0.7×	1.1k 0.9×	954 1.2×	433 0.9×	119 0.3×	152	2.6k
Sergiy M. Nadtochiy United States	27	1.7k 1.1×	842 0.7×	293 0.4×	1.0k 2.2×	257 0.7×	50	3.0k
Mary O. Gray United States	21	1.8k 1.2×	717 0.6×	880 1.1×	432 0.9×	151 0.4×	25	2.9k
Che-Hong Chen United States	17	1.5k 1.0×	838 0.7×	534 0.7×	475 1.0×	250 0.7×	18	2.7k
Marisol Ruiz‐Meana Spain	41	2.6k 1.7×	2.0k 1.6×	1.5k 1.9×	556 1.2×	225 0.7×	110	4.6k

Countries citing papers authored by Grant R. Budas

Since Specialization

Citations

This map shows the geographic impact of Grant R. Budas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grant R. Budas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grant R. Budas more than expected).

Fields of papers citing papers by Grant R. Budas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grant R. Budas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grant R. Budas. The network helps show where Grant R. Budas may publish in the future.

Co-authorship network of co-authors of Grant R. Budas

This figure shows the co-authorship network connecting the top 25 collaborators of Grant R. Budas. A scholar is included among the top collaborators of Grant R. Budas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grant R. Budas. Grant R. Budas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Peng, Zhenwei, Guangyan Wei, Pinzhu Huang, et al.. (2024). ASK1/p38 axis inhibition blocks the release of mitochondrial “danger signals” from hepatocytes and suppresses progression to cirrhosis and liver cancer. Hepatology. 80(2). 346–362. 7 indexed citations

Hollenback, David, Eva Hambruch, Andreas Schulz, et al.. (2024). Development of Cilofexor, an Intestinally-Biased Farnesoid X Receptor Agonist, for the Treatment of Fatty Liver Disease. Journal of Pharmacology and Experimental Therapeutics. 389(1). 61–75. 3 indexed citations

Fuchs, Claudia, Hubert Scharnagl, Ruchi Gupta, et al.. (2023). Non-steroidal FXR agonist cilofexor improves cholestatic liver injury in the Mdr2-/- mouse model of sclerosing cholangitis. JHEP Reports. 5(11). 100874–100874. 15 indexed citations

Budas, Grant R., et al.. (2021). Activation of PKCε-ALDH2 Axis Prevents 4-HNE-Induced Pain in Mice. Biomolecules. 11(12). 1798–1798. 8 indexed citations

Schwabl, Philipp, Eva Hambruch, Grant R. Budas, et al.. (2021). The Non-Steroidal FXR Agonist Cilofexor Improves Portal Hypertension and Reduces Hepatic Fibrosis in a Rat NASH Model. Biomedicines. 9(1). 60–60. 49 indexed citations

Wilson, K., Kornelija Suveizdytė, John T. Liles, et al.. (2020). Apoptosis signal‐regulating kinase 1 inhibition in in vivo and in vitro models of pulmonary hypertension. Pulmonary Circulation. 10(2). 1–16. 5 indexed citations

Budas, Grant R., Mario Boehm, Baktybek Kojonazarov, et al.. (2017). ASK1 Inhibition Halts Disease Progression in Preclinical Models of Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 197(3). 373–385. 77 indexed citations

Budas, Grant R., Faquan Liang, Dillon Phan, et al.. (2014). ASK1 promotes maladaptive remodeling in a rodent model of pulmonary hypertension. European Respiratory Journal. 44(Suppl 58). P2298–P2298. 3 indexed citations

Viatchenko‐Karpinski, Serge, Dmytro Kornyeyev, Nesrine El‐Bizri, et al.. (2014). Intracellular Na+ overload causes oxidation of CaMKII and leads to Ca2+ mishandling in isolated ventricular myocytes. Journal of Molecular and Cellular Cardiology. 76. 247–256. 50 indexed citations

10.

Toldo, Stefano, David G. Breckenridge, Eleonora Mezzaroma, et al.. (2012). Inhibition of Apoptosis Signal–Regulating Kinase 1 Reduces Myocardial Ischemia–Reperfusion Injury in the Mouse. Journal of the American Heart Association. 1(5). e002360–e002360. 40 indexed citations

11.

Ferreira, Julio Cesar Batista, Tomoyoshi Koyanagi, Suresh S. Palaniyandi, et al.. (2011). Pharmacological inhibition of βIIPKC is cardioprotective in late-stage hypertrophy. Journal of Molecular and Cellular Cardiology. 51(6). 980–987. 33 indexed citations

12.

Budas, Grant R., et al.. (2009). Aldehyde Dehydrogenase 2 in Cardiac Protection: A New Therapeutic Target?. Trends in Cardiovascular Medicine. 19(5). 158–164. 94 indexed citations

13.

Budas, Grant R., Marie‐Hélène Disatnik, Che‐Hong Chen, & Daria Mochly‐Rosen. (2009). Activation of aldehyde dehydrogenase 2 (ALDH2) confers cardioprotection in protein kinase C epsilon (PKCɛ) knockout mice. Journal of Molecular and Cellular Cardiology. 48(4). 757–764. 86 indexed citations

14.

Budas, Grant R., Tomoyoshi Koyanagi, Eric N. Churchill, & Daria Mochly‐Rosen. (2007). Competitive inhibitors and allosteric activators of protein kinase C isoenzymes: a personal account and progress report on transferring academic discoveries to the clinic. Biochemical Society Transactions. 35(5). 1021–1026. 24 indexed citations

15.

Budas, Grant R., Mair E. A. Churchill, & Daria Mochly‐Rosen. (2007). Cardioprotective mechanisms of PKC isozyme-selective activators and inhibitors in the treatment of ischemia-reperfusion injury☆. Pharmacological Research. 55(6). 523–536. 131 indexed citations

16.

Jovanović, Aleksandar, Qingyou Du, Grant R. Budas, et al.. (2006). AMP‐activated protein kinase mediates preconditioning in cardiomyocytes by regulating activity and trafficking of sarcolemmal ATP‐sensitive K⁺ channels. Journal of Cellular Physiology. 210(1). 224–236. 114 indexed citations

17.

Sakamoto, Kei, Elham Zarrinpashneh, Grant R. Budas, et al.. (2005). Deficiency of LKB1 in heart prevents ischemia-mediated activation of AMPKα2 but not AMPKα1. American Journal of Physiology-Endocrinology and Metabolism. 290(5). E780–E788. 185 indexed citations

18.

Ranki, Harri, Grant R. Budas, Russell M. Crawford, Anthony M. Davies, & Aleksandar Jovanović. (2002). 17β-Estradiol regulates expression of KATPchannels in heart-derived H9c2 cells. Journal of the American College of Cardiology. 40(2). 367–374. 94 indexed citations

19.

Ranki, Harri, Grant R. Budas, Russell M. Crawford, & Aleksandar Jovanović. (2001). Gender-specific difference in cardiac ATP-sensitive K+channels. Journal of the American College of Cardiology. 38(3). 906–915. 93 indexed citations

20.

Budas, Grant R., Christina Coughlan, Jonathan R. Seckl, & Kieran C. Breen. (1999). The effect of corticosteroids on amyloid β precursor protein/amyloid precursor-like protein expression and processing in vivo. Neuroscience Letters. 276(1). 61–64. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact